| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/19/2005 | EP1497019A1 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/19/2005 | EP1496945A1 Mycoplasma polypeptides |
| 01/19/2005 | EP1496942A1 Microparticles comprising carbohydrate beads covalently linked with allergen |
| 01/19/2005 | EP1496941A1 Glycodendrimers having biological activity |
| 01/19/2005 | EP1496934A2 Adjuvant enhanced immunotherapy |
| 01/19/2005 | EP1496920A1 Pharmaceutical composition containing an extract from barleria prionitis linn and its process of preparation |
| 01/19/2005 | EP1496917A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 01/19/2005 | EP1496914A1 (20S)-1a-HYDROXY-2a-METHYL AND 2&bgr;-METHYL-19-NOR-VITAM IN D sb 3 /sb AND THEIR USES |
| 01/19/2005 | EP1496910A1 Kinase inhibitors |
| 01/19/2005 | EP1496907A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496900A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 01/19/2005 | EP1496898A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496897A1 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/19/2005 | EP1496882A1 Tolterodine salts |
| 01/19/2005 | EP1496873A2 Chewable soft capsule |
| 01/19/2005 | EP1496863A2 Preparation and use of a stable formulation of allosteric effector compounds |
| 01/19/2005 | EP1496857A1 Aerosol containing a particulate active substance |
| 01/19/2005 | EP1496743A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/19/2005 | EP1414475B1 An herbal composition for the treatment and remedy of bronchial respiratory difficulties |
| 01/19/2005 | EP1395268B1 A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation |
| 01/19/2005 | EP1392366A4 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 01/19/2005 | EP1377574B1 6-phenylbenzonaphthyridines |
| 01/19/2005 | EP1313738A4 Process for the preparation and purification of thiol-containing maytansinoids |
| 01/19/2005 | EP1265615B1 Novel combination of non-sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjunctivitis |
| 01/19/2005 | EP1063228B1 Cycloalkene derivatives, process for producing the same, and use |
| 01/19/2005 | EP0994880B1 Crystalline macrolides and process for their preparation |
| 01/19/2005 | EP0789588B1 Method for making a medicament for treating secondary immunodeficiency |
| 01/19/2005 | CN1568373A RNA interference mediating small rna molecules |
| 01/19/2005 | CN1568369A Hybrid interferon/interferon Tau proteins, compositions and methods of use |
| 01/19/2005 | CN1568365A Composition comprising a lactobacillus pentosus strain and uses thereof |
| 01/19/2005 | CN1568331A Biological products |
| 01/19/2005 | CN1568330A Glycosylphosphatidylinositol containing polypeptides |
| 01/19/2005 | CN1568328A Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient |
| 01/19/2005 | CN1568322A Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
| 01/19/2005 | CN1568320A 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 01/19/2005 | CN1568308A Salts of guanidine derivatives and pharmaceutical preparations consisting thereof |
| 01/19/2005 | CN1568197A Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder |
| 01/19/2005 | CN1568196A Nutrient therapy for immuno-compromised patients |
| 01/19/2005 | CN1568193A Use of il-18 inhibitors in hypersensitivity disorders |
| 01/19/2005 | CN1568188A Nociceptin analogs |
| 01/19/2005 | CN1566160A Mu Shen polysaccharide and its immunoregulation and anticancer function |
| 01/19/2005 | CN1566151A Sugar latticeing material CHB extracted from serum of turtle or/and tortoise, preparation process and application in pharmacy thereof |
| 01/19/2005 | CN1566124A Cornel extract and use thereof |
| 01/19/2005 | CN1566054A Resveratrol oligo cattail compounds, its manufacturing process, pharmaceutical combination and uses thereof |
| 01/19/2005 | CN1565627A Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 01/19/2005 | CN1565581A Immune function regulating antibiotic and anti-inflammatory drug with broad spectrum |
| 01/19/2005 | CN1565552A Chinese traditional medicine for treating immune hypofunction and disfunction |
| 01/19/2005 | CN1565474A Biochemical nucleic acid fulvic acid oral liquid production method |
| 01/19/2005 | CN1565469A Cornel extract oral medicine compositions low irritative to gastrointestinal tract and its preparation |
| 01/19/2005 | CN1565453A 6-amino-ª‡(R)-hydroxyl-9H-purin-9-ethyl butyrate immunological suppression effect |
| 01/19/2005 | CN1565444A Ramatroban glue pill and its preparation method |
| 01/19/2005 | CN1185253C Neoglycoproteins |
| 01/19/2005 | CN1185250C Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/19/2005 | CN1185232C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 01/19/2005 | CN1185229C 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 01/19/2005 | CN1185227C Novel compounds |
| 01/19/2005 | CN1185226C Intermediate for preparing benzothiophene amide derivate |
| 01/19/2005 | CN1185215C Substituted glutarimides and use as IL-12 production inhibitors thereof |
| 01/19/2005 | CN1185213C Azetidine derivatives, preparation and pharmaceutical compositions thereof |
| 01/19/2005 | CN1185212C Salicylamide derivatives |
| 01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
| 01/19/2005 | CN1185009C Eye preparation |
| 01/19/2005 | CN1184961C Use of EGF-R antagonists in preparing drug |
| 01/18/2005 | US6844457 Antiproliferative agents; anticancer agents; antiinflammatory agents |
| 01/18/2005 | US6844456 Administering steriods (e.g. estrogens), wherein a non-fused polycyclic, hydrophobic substituent such as adamantanyl is attached to the hydroxy-substituted A-ring thereof |
| 01/18/2005 | US6844435 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 01/18/2005 | US6844365 Using diacerein or a pharmaceutically acceptable derivative or rhein for the manufacture of a pharmaceutical formulation for the treatment of psoriasis and diseases associated therewith |
| 01/18/2005 | US6844360 Cellular adhesion molecule and leukointegrin inhibitors; inflammatory diseases; more slowly metabolized |
| 01/18/2005 | US6844359 As inhibitors of tumor necrosis factor; for therapy of cachexia, arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, congestive heart failure, Crohn's disease, ulcerative colitis, systemic lupus erythrematosis |
| 01/18/2005 | US6844343 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 01/18/2005 | US6844341 Cell cycle kinase inhibitors; such as 2-(4-(N-(2-methoxy-ethyl)-sulphamoyl)anilino)-4-(imidazo(1,2b)pyridazin-3 -yl)-pyrimidine |
| 01/18/2005 | US6844332 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 01/18/2005 | US6844331 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 01/18/2005 | US6844330 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-NOR-vitamin D3 and their uses |
| 01/18/2005 | US6844328 Antiproliferative activity; low systemic toxicity; psoriasis, tumors, rheumatoid arthritis, intestinal inflammation |
| 01/18/2005 | US6844323 Polypeptide-calcitonin 11 and the polynucleotide encoding it |
| 01/18/2005 | US6844179 Protein and DNA thereof |
| 01/18/2005 | US6844175 Methods of inhibition using glycosyl sulfotransferase-3 |
| 01/18/2005 | US6844011 Methods for inhibiting rejection of transplanted tissue |
| 01/18/2005 | US6844001 Adjuvants and copolymer compositions |
| 01/18/2005 | US6843992 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 01/18/2005 | US6843991 Use of the M3 protein of MHV68 to block binding of a chemokine to its receptor |
| 01/18/2005 | US6843989 Administering a CD40 binding protein that potentiates the binding of CD40 to CD40 ligand |
| 01/18/2005 | CA2269638C Ice inhibiting peptides |
| 01/18/2005 | CA2144043C Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/13/2005 | WO2005003335A2 Rapamycin resistant t cells and therapeutic uses thereof |
| 01/13/2005 | WO2005003145A1 Shanzhuyu extract and uses thereof |
| 01/13/2005 | WO2005003143A1 Novel potassium channel modulators |
| 01/13/2005 | WO2005003094A1 Diarylmethyl derivatives as potassium channel modulators |
| 01/13/2005 | WO2005002613A1 Pharmaceutical compositions comprising an epitope of platelet gpiiia protein |
| 01/13/2005 | WO2005002558A1 Preventive and/or therapeutic agent for inflammatory bowel disease |
| 01/13/2005 | WO2005002512A2 Immunotherapeutic vaccine strategy |
| 01/13/2005 | WO2004075907A3 Salutary compositions consisting of fungi containing lipids and thiocyanates |
| 01/13/2005 | WO2004072047A8 Indoles, benzimidazoles or naphhimidazoles as histone deacetylase (hdac) inhibitors |
| 01/13/2005 | WO2004069876A3 Trimeric polypeptide construct to induce an enduring t cell response |
| 01/13/2005 | US20050010047 Angiogenesis inhibitors; psoriasis; rheumatic disorders; chronic obstructive pulmonary disease |
| 01/13/2005 | US20050010042 Expression vector comprising nucleotide sequences comprising pro-polypeptide for use in the diagnosis, prevention and treatment of cell proliferative, inflammatory, cardiovascuar and nervous system disorders |
| 01/13/2005 | US20050009917 Prostaglandin, e.g., 1R,2R,3R,5R)-5-halo-2-[(1E,3S)-3-cycloalkyl-3-hydroxy-1-propenyl]-3-hydroxycyclopentyl]-(5Z)-5-alkenoic acids; treating in particular, symptoms of atopic dermatitis |
| 01/13/2005 | US20050009894 Benzimidazole derivatives and their use as KDR kinase protein inhibitors |